Resonance Specialities (BSE 524218)₹297.75+21.28%Specialty Chemicals
In the Jun 2026 quarter (standalone), Resonance Specialities reported sales of ₹32.61 Cr, up 53.2% from Jun 2025, and net profit of ₹5.73 Cr, up 253.7% year on year. For the year to Mar 2026, sales were ₹90.01 Cr and net profit ₹9.98 Cr.
Company filings, standalone accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 10.15 | 15.36 | 16.37 | 17.31 | 18.08 | 18.26 | 24.21 | 21.29 | 21.56 | 22.97 | 24.49 | 32.61 |
| Expenses | 9.23 | 14.05 | 15.33 | 15.23 | 15.73 | 16.37 | 19.96 | 18.75 | 19.18 | 19.55 | 18.87 | 25.15 |
| Operating Profit | 0.93 | 1.33 | 1.06 | 2.09 | 2.36 | 1.90 | 4.26 | 2.56 | 2.37 | 3.46 | 5.66 | 7.48 |
| OPM % | 9.1% | 8.7% | 6.5% | 12.1% | 13.1% | 10.4% | 17.6% | 12.1% | 11.0% | 15.1% | 23.1% | 23.0% |
| Other Income | 0.24 | 0.24 | 0.28 | −0.63 | 0.44 | 0.29 | 0.06 | 0.22 | 0.34 | 0.31 | 0.73 | 0.53 |
| Interest | 0.08 | 0.10 | 0.11 | 0.09 | 0.09 | 0.07 | 0.02 | 0.07 | 0.05 | 0.04 | 0.04 | 0.00 |
| Depreciation | 0.35 | 0.37 | 0.36 | 0.47 | 0.48 | 0.47 | 0.10 | 0.32 | 0.32 | 0.33 | 0.33 | 0.33 |
| Profit before tax | 0.73 | 1.09 | 0.86 | 0.87 | 2.22 | 1.64 | 4.19 | 2.38 | 2.33 | 3.39 | 6.00 | 7.66 |
| Tax % | 36.2% | 11.2% | 21.3% | 31.5% | 18.2% | 32.0% | 26.9% | 31.3% | 28.9% | 26.1% | 23.5% | 25.1% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 0.45 | 0.95 | 0.66 | 0.58 | 1.80 | 1.11 | 3.05 | 1.62 | 1.65 | 2.50 | 4.59 | 5.73 |
| EPS (Rs) | 0.39 | 0.82 | 0.57 | 0.50 | 1.56 | 0.96 | 2.64 | 1.40 | 1.43 | 2.16 | 3.97 | 4.96 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 39.01 | 34.04 | 36.04 | 41.05 | 56.03 | 70.02 | 76.10 | 58.08 | 55.04 | 78.04 | 90.01 | 102 |
| Expenses | 36.03 | 32.05 | 35.04 | 37.04 | 48.06 | 56.04 | 59.06 | 51.07 | 50.06 | 67.05 | 76.11 | 82.75 |
| Operating Profit | 3.01 | 2.01 | 1.01 | 5.01 | 8.02 | 14.03 | 17.03 | 7.01 | 5.01 | 11.02 | 14.04 | 18.97 |
| OPM % | 8.1% | 6.0% | 1.8% | 12.1% | 14.0% | 20.1% | 22.1% | 12.1% | 9.1% | 14.1% | 16.1% | 18.7% |
| Other Income | 0.00 | 0.99 | 0.99 | 0.99 | 0.00 | 1.99 | 0.99 | 1.99 | 0.99 | 0.00 | 1.99 | 1.91 |
| Interest | 0.99 | 0.00 | 0.99 | 0.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.13 |
| Depreciation | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 0.99 | 1.99 | 0.99 | 0.99 | 1.99 | 0.99 | 1.31 |
| Profit before tax | 2.01 | 1.01 | 0.00 | 5.01 | 7.01 | 15.02 | 16.02 | 7.01 | 4.01 | 9.01 | 14.02 | 19.38 |
| Tax % | 28.1% | 26.1% | 2,700.1% | 33.1% | 20.1% | 28.1% | 24.1% | 27.1% | 25.1% | 26.1% | 26.1% | — |
| Exceptional items | 0.00 | −0.01 | 0.44 | −0.05 | −1.12 | 0.00 | 0.05 | 0.00 | 0.00 | −0.50 | 0.12 | 0.00 |
| Net Profit | 0.99 | 0.99 | −0.99 | 2.99 | 5.99 | 10.99 | 11.99 | 4.99 | 2.99 | 6.99 | 9.98 | 14.47 |
| EPS (Rs) | 1.02 | 0.88 | −0.66 | 2.76 | 4.76 | 9.09 | 10.69 | 4.32 | 2.56 | 5.68 | 9.00 | 12.52 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 21.0% | 11.0% | 9.0% | 23.0% | 0.0% | 18.0% | 11.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11.96 | 11.98 | 11.96 | 11.96 | 11.95 | 11.96 | 11.96 | 11.96 | 11.97 | 11.96 | 11.97 | 11.97 |
| Reserves | 10.00 | 11.00 | 11.98 | 11.99 | 14.99 | 18.99 | 28.97 | 40.00 | 43.97 | 45.97 | 51.96 | 61.98 |
| Borrowings | 2.99 | 1.99 | 3.99 | 2.99 | 0.00 | 0.00 | 0.99 | 0.00 | 1.99 | 3.99 | 2.99 | 1.99 |
| Other Liabilities | 10.05 | 8.04 | 12.06 | 10.02 | 12.02 | 11.04 | 13.06 | 5.02 | 8.04 | 12.04 | 8.04 | 17.08 |
| Total Liabilities | 35.00 | 32.01 | 39.99 | 36.96 | 37.96 | 40.99 | 54.98 | 56.98 | 65.97 | 73.96 | 75.96 | 92.02 |
| Fixed Assets | 14.02 | 14.02 | 15.03 | 15.01 | 14.01 | 14.02 | 16.03 | 14.01 | 20.03 | 23.03 | 21.04 | 21.04 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.99 | 0.99 | 1.99 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 3.99 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | 0.00 | 0.00 | 3.01 | 0.00 | 12.03 |
| Other Assets | 19.98 | 17.99 | 24.96 | 21.96 | 22.96 | 24.98 | 37.94 | 41.97 | 44.94 | 47.92 | 53.93 | 56.96 |
| Inventories | 7.58 | 8.02 | 13.62 | 9.96 | 8.92 | 13.42 | 16.64 | 11.70 | 23.21 | 22.91 | 26.33 | 34.45 |
| Trade receivables | 10.26 | 6.97 | 7.39 | 6.63 | 7.55 | 6.12 | 9.39 | 8.18 | 12.30 | 13.29 | 22.31 | 13.85 |
| Cash & equivalents | 0.86 | 0.87 | 0.57 | 0.59 | 1.71 | 2.46 | 5.88 | 8.57 | 4.30 | 2.17 | 0.61 | 0.61 |
| Total Assets | 35.00 | 32.01 | 39.99 | 36.96 | 37.96 | 40.99 | 54.98 | 56.98 | 65.97 | 73.96 | 75.96 | 92.02 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 1.01 | 3.01 | 1.01 | 2.01 | 5.01 | 1.01 | 4.01 | 13.03 | −8.02 | 4.01 | −3.01 | 17.04 |
| Cash from investing activity | 0.00 | −0.99 | −2.99 | −0.99 | 0.00 | −1.99 | −0.99 | −8.96 | 2.99 | −6.98 | 3.98 | −14.94 |
| Cash from financing activity | −1.99 | −1.99 | 2.01 | −0.99 | −4.01 | 0.99 | 0.00 | −1.99 | 0.99 | 0.00 | −1.01 | −2.01 |
| Net cash flow | −1.01 | 0.00 | 0.00 | 0.00 | 1.01 | 1.01 | 3.01 | 3.01 | −4.01 | −2.01 | 0.00 | 0.00 |
| Capex | 0.27 | 0.81 | 2.61 | 1.15 | 0.63 | 1.96 | 0.84 | 0.60 | 7.59 | 4.41 | 1.19 | 3.73 |
| Free cash flow | 0.99 | 1.99 | −1.99 | 0.99 | 4.99 | −0.99 | 2.99 | 12.96 | −15.96 | 0.00 | −3.99 | 13.97 |
| CFO / OP % | 103.1% | 122.0% | 28.1% | 362.1% | 107.1% | 47.0% | 61.1% | 110.1% | −92.9% | 117.1% | −5.0% | 141.1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 99 | 66 | 80 | 68 | 67 | 40 | 49 | 40 | 78 | 89 | 105 | 56 |
| Inventory days | 134 | 159 | 397 | 212 | 180 | 232 | 236 | 176 | 646 | 341 | 316 | 319 |
| Days payable | 117 | 109 | 263 | 128 | 140 | 115 | 122 | 18 | 139 | 135 | 66 | 114 |
| Cash conversion cycle | 117 | 117 | 215 | 152 | 108 | 158 | 164 | 198 | 587 | 295 | 356 | 263 |
| Working capital days | 72 | 75 | 86 | 81 | 94 | 83 | 100 | 144 | 213 | 222 | 207 | 157 |
| ROCE % | 4.0% | 9.0% | 7.0% | 2.0% | 19.9% | 30.9% | 40.9% | 34.9% | 12.9% | 7.0% | 15.0% | 19.9% |
For the Jun 2026 quarter, Resonance Specialities reported sales of ₹32.61 Cr, up 53.2% year on year and net profit of ₹5.73 Cr, up 253.7% year on year. The operating margin was 23.0%.
Resonance Specialities' sales for the year to Mar 2026 were ₹90.01 Cr; over the last twelve months they were ₹102 Cr.
Net profit for the year to Mar 2026 was ₹9.98 Cr, and ₹14.47 Cr over the last twelve months. Earnings per share over the same trailing period were ₹12.52.
Resonance Specialities reported borrowings of ₹1.99 Cr at Mar 2026, against cash and equivalents of ₹0.61 Cr.
Cash from operations was ₹17.04 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹13.97 Cr.